BAJAJ BROKING

Notification
No new Notification messages
NAPS Global India IPO is Open!
Apply for the NAPS Global India IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

Apollo Hospitals Invests ₹250 Crore in India’s First Proteus One System

Synopsis:

Apollo Hospitals Enterprise Ltd plans to invest ₹250 crore in India’s first Proteus One proton therapy system in Hyderabad. The facility, set to be operational by FY2028, will increase annual cancer treatment capacity by 350 patients. The investment is funded through internal accruals.


Apollo Hospitals Enterprise Ltd has announced a significant investment of ₹250 crore to establish India’s first Proteus One proton therapy system in Hyderabad. The advanced oncology centre will expand the hospital chain’s existing proton therapy capabilities and is expected to become operational by FY2028. The investment, fully funded through internal accruals, aims to enhance cancer treatment accessibility in India.

Also read: Dr Reddy’s Sells 14-Drug Portfolio to Senores Pharma for US Market Growth

APOLLO HOSPITALS ENTER. L

Trade

6207.8-66.30 (-1.05 %)

Updated - 07 March 2025
6314.75day high
DAY HIGH
6197.30day low
DAY LOW
299433
VOLUME (BSE)

Key Takeaways:

  • Investment Amount: ₹250 crore

  • Facility Location: Hyderabad

  • Expected Operational Year: FY2028

  • Annual Treatment Capacity: 350 additional patients

  • Existing Chennai Proton Centre Capacity: 850 patients per year

  • Technology Partner: Ion Beam Applications (IBA)

Also read: Welspun Specialty Wins ₹231.77 Crore BHEL Contract for Boiler Tubes

Expanding Cancer Treatment with Advanced Proton Therapy

Apollo Hospitals currently operates a proton therapy centre in Chennai, which treats over 500 cancer patients annually. The Chennai facility, designed for a capacity of 850 patients, was South Asia’s first proton therapy centre when launched in 2019. The new Hyderabad centre will add to this capacity, allowing an additional 350 patients to receive cutting-edge cancer treatment each year.

The Proteus One system, developed by Ion Beam Applications (IBA), is a state-of-the-art single-room proton therapy solution known for its precision and efficiency in targeting tumours. Proton therapy is widely recognised for its benefits in treating complex cancers, including central nervous system tumours, paediatric cancers, and head and neck malignancies.

Project Details

Information

Investment Amount

₹250 crore

Location

Hyderabad

Expected Completion

FY2028

Technology Provider

Ion Beam Applications (IBA)

New Treatment Capacity

350 additional patients/year

Current Chennai Centre Capacity

850 patients/year

Apollo Hospitals Enterprise Ltd Share Price Movement

Following the announcement, Apollo Hospitals Enterprise Ltd share price closed at ₹6,183.45, reflecting a marginal gain of ₹6.30 or 0.10% on the BSE. Investors are closely monitoring the impact of this expansion on the company’s long-term growth in the healthcare sector.

Apollo Hospitals Enterprise Ltd continues to strengthen its position as a leader in cancer care by introducing advanced treatment solutions in India. The ₹250 crore investment in Hyderabad’s Proteus One system highlights its commitment to expanding proton therapy, improving patient outcomes, and enhancing its oncology infrastructure. With the project set to be completed by FY2028, Apollo Hospitals is poised to redefine cancer treatment accessibility in the country.

Also read: Power Grid Wins Bids for 3 Interstate Transmission Projects Under BOOT Model

Do you have a trading account app or demat account app?

You can open an account with Bajaj Broking in minutes.

Download the Bajaj Broking app now from Play Store or App Store.

Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.

This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

For All Disclaimers Click Here: https://www.bajajbroking.in/disclaimer

Share this article: 

Read More Blogs

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

9 lakh+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300+ Cr MTF Book

icon-with-text